190 related articles for article (PubMed ID: 35945246)
1. Unexpected diagnosis of myotonic dystrophy type 2 repeat expansion by genome sequencing.
Rafehi H; Green C; Bozaoglu K; Gillies G; Delatycki MB; Lockhart PJ; Scheffer IE; Bahlo M
Eur J Hum Genet; 2023 Jan; 31(1):122-124. PubMed ID: 35945246
[TBL] [Abstract][Full Text] [Related]
2. Molecular Diagnosis of Myotonic Dystrophy.
Chakraborty S; Vatta M; Bachinski LL; Krahe R; Dlouhy S; Bai S
Curr Protoc Hum Genet; 2016 Oct; 91():9.29.1-9.29.19. PubMed ID: 27727437
[TBL] [Abstract][Full Text] [Related]
3. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.
Liquori CL; Ikeda Y; Weatherspoon M; Ricker K; Schoser BG; Dalton JC; Day JW; Ranum LP
Am J Hum Genet; 2003 Oct; 73(4):849-62. PubMed ID: 14505273
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
[TBL] [Abstract][Full Text] [Related]
5. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
[TBL] [Abstract][Full Text] [Related]
6. Characterization of full-length
Alfano M; De Antoni L; Centofanti F; Visconti VV; Maestri S; Degli Esposti C; Massa R; D'Apice MR; Novelli G; Delledonne M; Botta A; Rossato M
Elife; 2022 Aug; 11():. PubMed ID: 36018009
[TBL] [Abstract][Full Text] [Related]
7. Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus.
Radvanszky J; Surovy M; Polak E; Kadasi L
Neuromuscul Disord; 2013 Jul; 23(7):591-8. PubMed ID: 23561036
[TBL] [Abstract][Full Text] [Related]
8. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
[TBL] [Abstract][Full Text] [Related]
9. Optimization PCR for Detection CTG/CCTG-Repeat Expansions in the Diagnosis of Myotonic Dystrophies.
Meng YX; Shen HR; Zhao Z; Bing Q; Li N; Hu J
Ann Clin Lab Sci; 2015; 45(5):502-7. PubMed ID: 26586700
[TBL] [Abstract][Full Text] [Related]
10. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.
Day JW; Ricker K; Jacobsen JF; Rasmussen LJ; Dick KA; Kress W; Schneider C; Koch MC; Beilman GJ; Harrison AR; Dalton JC; Ranum LP
Neurology; 2003 Feb; 60(4):657-64. PubMed ID: 12601109
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic uplift through the implementation of short tandem repeat analysis using exome sequencing.
Yoon JG; Lee S; Cho J; Kim N; Kim S; Kim MJ; Kim SY; Moon J; Chae JH
Eur J Hum Genet; 2024 May; 32(5):584-587. PubMed ID: 38308084
[TBL] [Abstract][Full Text] [Related]
12. Premutation allele pool in myotonic dystrophy type 2.
Bachinski LL; Czernuszewicz T; Ramagli LS; Suominen T; Shriver MD; Udd B; Siciliano MJ; Krahe R
Neurology; 2009 Feb; 72(6):490-7. PubMed ID: 19020295
[TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
Liquori CL; Ricker K; Moseley ML; Jacobsen JF; Kress W; Naylor SL; Day JW; Ranum LP
Science; 2001 Aug; 293(5531):864-7. PubMed ID: 11486088
[TBL] [Abstract][Full Text] [Related]
14. Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy.
Sznajder ŁJ; Swanson MS
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323950
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide sequencing as a first-tier screening test for short tandem repeat expansions.
Rajan-Babu IS; Peng JJ; Chiu R; ; ; Li C; Mohajeri A; Dolzhenko E; Eberle MA; Birol I; Friedman JM
Genome Med; 2021 Aug; 13(1):126. PubMed ID: 34372915
[TBL] [Abstract][Full Text] [Related]
16. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
Kumar A; Agarwal S; Agarwal D; Phadke SR
Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
[TBL] [Abstract][Full Text] [Related]
18. Analysis of repetitive regions in myotonic dystrophy type 1 and 2.
Carson NL
Curr Protoc Hum Genet; 2009 Apr; Chapter 9():Unit 9.6. PubMed ID: 19360700
[TBL] [Abstract][Full Text] [Related]
19. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
20. Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing.
Radvansky J; Ficek A; Kadasi L
Genet Test Mol Biomarkers; 2011 Mar; 15(3):133-6. PubMed ID: 21204698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
